Viewing StudyNCT00105456



Ignite Creation Date: 2024-05-05 @ 11:41 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00105456
Status: COMPLETED
Last Update Posted: 2010-05-06
First Post: 2005-03-14

Brief Title: A Study of Patients With HER2-Positive Metastatic Breast Cancer
Sponsor:
Organization: Genentech Inc

Study Design

Study Type: OBSERVATIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 1000
Enrollment Type: None
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Name
Cohort
Time Perspective List:

Clinical Trial Statuses

Name
611
Who Masked List: